NEWS

Biogen Shares Tumble as Alzheimer’s Drug Study Is Halted

Biogen Shares Tumble as Alzheimer’s Drug Study Is Halted

Mar.21 — Biogen Inc. announced it was halting research on its experimental Alzheimer’s drug as it was unlikely to be effective. Bloomberg Opinion columnist Max Nisen reports on “Bloomberg Daybreak: Americas.” His opinions are his own.

View on YouTube

Channel:Bloomberg Markets and Finance

U-RanTV
U-RanTV
I get it!